A detailed history of Credit Suisse Ag transactions in Danaher Corp stock. As of the latest transaction made, Credit Suisse Ag holds 1,473,168 shares of DHR stock, worth $340 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
1,473,168
Previous 1,848,755 20.32%
Holding current value
$340 Million
Previous $428 Million 13.98%
% of portfolio
0.36%
Previous 0.42%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$224.58 - $256.19 $84.3 Million - $96.2 Million
-375,587 Reduced 20.32%
1,473,168 $368 Million
Q4 2023

Feb 08, 2024

BUY
$185.1 - $233.13 $9.19 Million - $11.6 Million
49,669 Added 2.76%
1,848,755 $428 Million
Q3 2023

Nov 13, 2023

SELL
$233.08 - $265.59 $7.03 Million - $8.01 Million
-30,175 Reduced 1.65%
1,799,086 $446 Million
Q2 2023

Aug 11, 2023

BUY
$224.99 - $256.14 $48.1 Million - $54.7 Million
213,646 Added 13.22%
1,829,261 $439 Million
Q1 2023

May 10, 2023

SELL
$239.75 - $277.0 $12.3 Million - $14.2 Million
-51,325 Reduced 3.08%
1,615,615 $407 Million
Q4 2022

Feb 13, 2023

SELL
$241.42 - $282.29 $29.2 Million - $34.1 Million
-120,755 Reduced 6.75%
1,666,940 $443 Million
Q3 2022

Nov 10, 2022

BUY
$247.06 - $1507.4 $51.4 Million - $314 Million
208,016 Added 13.17%
1,787,695 $462 Million
Q2 2022

Aug 12, 2022

SELL
$237.11 - $299.66 $16.2 Million - $20.5 Million
-68,312 Reduced 4.15%
1,579,679 $400 Million
Q1 2022

May 16, 2022

SELL
$257.27 - $315.76 $47.4 Million - $58.1 Million
-184,140 Reduced 10.05%
1,647,991 $483 Million
Q4 2021

Feb 14, 2022

BUY
$292.08 - $329.01 $87.6 Million - $98.7 Million
300,017 Added 19.58%
1,832,131 $603 Million
Q3 2021

Nov 12, 2021

BUY
$272.21 - $332.43 $4.27 Million - $5.22 Million
15,692 Added 1.03%
1,532,114 $466 Million
Q2 2021

Aug 16, 2021

SELL
$225.08 - $271.69 $59.2 Million - $71.5 Million
-263,233 Reduced 14.79%
1,516,422 $411 Million
Q1 2021

May 14, 2021

BUY
$212.38 - $245.9 $20 Million - $23.2 Million
94,270 Added 5.59%
1,779,655 $401 Million
Q4 2020

Feb 12, 2021

SELL
$212.5 - $245.46 $35.5 Million - $41 Million
-167,160 Reduced 9.02%
1,685,385 $374 Million
Q3 2020

Nov 13, 2020

BUY
$177.16 - $215.33 $24 Million - $29.1 Million
135,334 Added 7.88%
1,852,545 $399 Million
Q2 2020

Aug 12, 2020

SELL
$128.7 - $176.83 $19 Million - $26.2 Million
-148,016 Reduced 7.94%
1,717,211 $304 Million
Q1 2020

May 13, 2020

SELL
$121.39 - $169.05 $6.96 Million - $9.69 Million
-57,329 Reduced 2.98%
1,865,227 $258 Million
Q4 2019

Feb 12, 2020

BUY
$133.47 - $153.48 $16.9 Million - $19.5 Million
126,877 Added 7.07%
1,922,556 $295 Million
Q3 2019

Nov 12, 2019

BUY
$135.4 - $146.47 $17.2 Million - $18.6 Million
126,956 Added 7.61%
1,795,679 $259 Million
Q2 2019

Aug 14, 2019

SELL
$124.88 - $143.73 $21.9 Million - $25.2 Million
-175,034 Reduced 9.49%
1,668,723 $238 Million
Q1 2019

May 14, 2019

SELL
$97.62 - $132.29 $20.8 Million - $28.1 Million
-212,758 Reduced 10.35%
1,843,757 $243 Million
Q4 2018

Feb 13, 2019

SELL
$94.85 - $109.54 $6.52 Million - $7.53 Million
-68,725 Reduced 3.23%
2,056,515 $212 Million
Q3 2018

Nov 13, 2018

BUY
$98.13 - $108.9 $9.53 Million - $10.6 Million
97,132 Added 4.79%
2,125,240 $231 Million
Q2 2018

Aug 14, 2018

SELL
$96.1 - $103.24 $49,107 - $52,755
-511 Reduced 0.03%
2,028,108 $200 Million
Q1 2018

May 15, 2018

SELL
$92.16 - $103.8 $12.3 Million - $13.8 Million
-133,154 Reduced 6.16%
2,028,619 $199 Million
Q4 2017

Mar 14, 2018

BUY
$85.26 - $94.62 $6.41 Million - $7.11 Million
75,175 Added 3.6%
2,161,773 $201 Million
Q4 2017

Feb 14, 2018

SELL
$85.26 - $94.62 $3.11 Million - $3.45 Million
-36,447 Reduced 1.72%
2,086,598 $194 Million
Q3 2017

Nov 14, 2017

BUY
$79.29 - $88.45 $3.51 Million - $3.91 Million
44,261 Added 2.13%
2,123,045 $182 Million
Q2 2017

Aug 14, 2017

BUY
N/A
2,078,784
2,078,784 $178 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.